Treatment of neonatal sepsis with intravenous immune globulin
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Neonatal sepsis is a major cause of death and complications despite antibiotic treatment. Effective adjunctive treatments are needed. Newborn infants are relatively deficient in endogenous immunoglobulin. Meta-analyses of trials of intravenous immune globulin for suspected or proven neonatal sepsis suggest a reduced rate of death from any cause, but the trials have been small and have varied in quality.
Originalsprog | Engelsk |
---|---|
Tidsskrift | New England Journal of Medicine |
Vol/bind | 365 |
Udgave nummer | 13 |
Sider (fra-til) | 1201-11 |
Antal sider | 11 |
ISSN | 0028-4793 |
DOI | |
Status | Udgivet - 2011 |
ID: 40157036